Processing timeline
3
days
Filed
30 Mar 2026
Acquirer(s)
Catalyst Blocker Merger Sub I, LLC, Catalyst Blocker Merger Sub II, LLC, Catalyst Holdco Merger Sub, LLC, Catalyst Debt Merger Sub, LLC
Target(s) or Vendor(s)
CSHC Buyerco, LLC
Other parties
CSHC Holdings, LLC, Capsa Solutions, LLC, CSHC Fund Blocker, LLC, CSHC Co-Investment Blocker Corp., LLC, Francisco Partners Management, LP
Funds advised by Francisco Partners Management, LP, a global technology investment firm, will acquire 100% of CSHC Buyerco, LLC (Capsa Healthcare) via a share sale. Capsa Healthcare manufactures and supplies healthcare equipment and technology-enabled point-of-care hardware, including mobile medication carts, for the hospitals sector.
Francisco Partners Management, LP ( Francisco Partners ) is a global investment firm specialising in technology and technology-enabled businesses, headquartered in San Francisco, United States with offices in New York and London. Francisco Partners has several portfolio companies that operate across multiple sectors, including in Australia. CSHC Buyerco, LLC (together with its connected entities, Capsa Healthcare ) manufactures and supplies healthcare equipment and technology-enabled point-of-care hardware, including mobile medication carts, pharmacy automation hardware, clinical workstations, and medical supply chain software. Capsa Healthcare does not have a physical presence in Australia but does generate a proportion of its global revenue from supply to Australian customers. Pursuant to a share sale agreement and as described in the transaction documents provided as part of the application, the funds advised by Francisco Partners which are currently controlled by the acquiring vehicles will acquire 100% control and ownership of Capsa Healthcare.